The anti-malaria drug that President Trump touted as a possible treatment for coronavirus, hydroxychloroquine, successfully lowered the death rate among hospitalized COVID-19 patients in the most recent study of the drug. The large-scale analysis, conducted by Henry Ford Health System, was published Thursday in the peer-reviewed International Journal of Infectious Diseases. The study examined 2,541 patients who had been hospitalized in six hospitals between March 10 and May 2, 2020. More than twenty-six percent (26.4%) of patients who did not receive hydroxychloroquine died. …read more
Source: Sott health news feed
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr